PIUG Biotech 2023 - Plenary

6

PIUG 2023 Biotechnology Conference

 M O R N I N G S P E A K E R S

Understanding in Vitro Diagnostic Inventions: What Can Be Claimed andWhere? LisaMueller, Casimir Jones 9:45 – 10:30 am

 ABSTRACT The worldwide in vitro diagnostic market is expected to exceed $127 billion in 2022. Over the course of the last three years, there was a renewed understanding of the importance of diagnostic inventions in controlling and managing the spread of deadly viruses, such as COVID-19. Intellectual property protection for these inventions is critical to provide the incentive needed for companies to spend the millions of dollars needed to develop such tests, not only to protect against deadly viruses, but also to diagnose and monitor the treatment of diseases such as HIV, heart disease, Alzheimer’s disease and much more. This presentation will examine the types of patent claims available for diagnostic inventions in various jurisdictions and challenges associated with getting such claims.  BIOGRAPHY Lisa Mueller is a shareholder at Casimir Jones. For over twenty-five years, Lisa has provided strategic counsel on complex patent issues to clients in the plant, food, pharmaceutical, biopharmaceutical, biotechnology, diagnostic, and chemistry sectors. She brings an in-depth knowledge and extensive experience to her work advising clients on the global patent protection, freedom to operate and validity of the products they aim to produce and distribute. Lisa also edited and authored a chapter in the book entitled, “Global Patent Protection and Enforcement of In Vitro Diagnostic Inventions” published by Wolters Kluwer, and the host of the podcast, AUTM in the AIR, a weekly podcast which interviews the leaders in Technology Transfer. Lisa is also involved in a number of equity, diversity and inclusion initiatives, including the creator and instructor of the Casimir Jones Life Sciences Patent Academy and the Chair Elect of the AUTM Equity, Diversity and Inclusion Committee.